Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2001
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072744A1 N-heterocyclic derivatives as nos inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072680A1 Substituted chalcones as therapeutic compounds
10/04/2001WO2001072669A2 Therapeutic use of polyhydroxy amine derivates
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072315A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
10/04/2001WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease
10/04/2001WO2001047878A8 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/04/2001WO2001019322A3 Use of csaids in rhinovirus infection
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
10/04/2001WO2001000244A3 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001US20010027209 Canolide analogues or derivatives of 2-oxo-6,7,8,10,11,12-2H-benzo(1,2-b:3,4-b':5,6-b")tripyran; treating and prevention of mycobacterium infections; tuberculosis; HIV; viricides
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010027176 Cyclooxygenase inhibitor
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1137806A1 Detection of rantes gene promoter polymorphisms
10/04/2001EP1137805A1 Methods of facilitating vascular growth
10/04/2001EP1137762A1 Treatment of pompe's disease
10/04/2001EP1137667A2 Analogues of glp-1
10/04/2001EP1137666A1 Glp-1 analogues
10/04/2001EP1137661A1 Procollagen c-proteinase inhibitors
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137637A1 N-(2-phenyl-4-piperidinylbutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
10/04/2001EP1137439A2 Stabilization of macrolides
10/04/2001EP1137438A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
10/04/2001EP1137430A2 Therapeutic agent for the suppression of snoring noises
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP1137399A2 Improvements in or relating to powders
10/04/2001EP1137398A1 Pharmaceutical preparation for inhalation of an opioid
10/04/2001EP0880528B1 Spiro-ketal derivatives and their use as therapeutic agents
10/04/2001EP0815105B1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2404626A1 Novel piperazine derivatives
10/04/2001CA2404532A1 Method of identifying inhibitors of tie-2
10/04/2001CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001CA2404461A1 Human g-protein coupled receptors
10/04/2001CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404231A1 Methods of treating diseases with activated protein c
10/04/2001CA2404147A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
10/04/2001CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2402735A1 Human transcription factors
10/04/2001CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315861A Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for treatment of sleep disorders
10/03/2001CN1315190A Compound oral liquid of tandrilled fritillar bulb and its preparing process
10/03/2001CN1315189A Tea for treating cold and its preparing process
10/03/2001CN1315182A Compound antiasthmatic-antitussive tea and its preparing process
10/03/2001CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists
10/03/2001CN1072214C Biologically active benzothiazolone ethanamines
10/02/2001US6297399 Hypotensive agents
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297375 4-phenyl-pyridine derivatives
10/02/2001US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists
10/02/2001US6297264 E.g., 4-(2-benzyloxy-2-(3-cyclopentyloxy-4-methoxyphenyl)ethyl)pyrid ine; phosphodiesterase inhibitors
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/02/2001US6297257 Benzazine derivatives phosphodiesterase 4 inhibitors
10/02/2001US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases
10/02/2001US6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
10/02/2001US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter
10/02/2001US6297217 Boronic ester and acid compounds, synthesis and uses
10/02/2001US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1
10/02/2001US6296851 For screening antibiotics
09/2001
09/27/2001WO2001071358A1 Method of screening for inhibitors of osteopontin
09/27/2001WO2001071342A2 Identification of mast cell/basophil activation inhibitors
09/27/2001WO2001071004A2 Proteases
09/27/2001WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
09/27/2001WO2001070952A1 Human gata-5 transcription factor
09/27/2001WO2001070807A2 G-protein associated molecules
09/27/2001WO2001070766A2 Therapeutic anti-cytomegalovirus compounds
09/27/2001WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001WO2001070748A1 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS
09/27/2001WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof
09/27/2001WO2001070742A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
09/27/2001WO2001070740A1 Process for preparing crystalline form i of cabergoline
09/27/2001WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
09/27/2001WO2001070723A1 Benzothiophene derivatives and medicinal use thereof
09/27/2001WO2001070695A1 Pyridine derivatives as inhibitors of p38
09/27/2001WO2001070694A1 Amorphous torasemide modification
1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 878